A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy

NCT01184599 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Glomerulonephritis, IGA
Hypertension

Interventions

DRUG: aliskiren

Sponsor

Kagawa University